Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

Clinical trial NCT05305911 · RECRUITING

Trial details

NCT number: NCT05305911
Sponsor: Minneapolis Heart Institute Foundation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Attack Enlarged Heart

Start date: 2022-08-03
Primary completion: 2028-12-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.